This site is intended for US Healthcare Professionals only.
To report an adverse reaction or product complaint, call 1-888-BLUPRNT, option 2, or visit or contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Search Medical Information

Clinical trials

Explore clinical trials in the Blueprint Medicines pipeline

  • Clinical Trial Name
  • Title
  • Status
  • Phase
  • Study number
  • Clinical Trial Name PATHFINDER: A Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, in Patients with Advanced Systemic Mastocytosis
  • Title

  • Status

  • Phase

  • Study number NCT03580655
  • Clinical Trial Name PIONEER: A Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), a Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, Versus Placebo in Patients With Indolent Systemic Mastocytosis
  • Title

  • Status

  • Phase

  • Study number NCT03731260
  • Clinical Trial Name HARBOR: A Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis
  • Title

  • Status

  • Phase

  • Study number NCT04910685
  • Clinical Trial Name AZURE: A Study of Elenestinib (BLU-263) in Advanced Systemic Mastocytosis (AdvSM) and and Other KIT Altered Hematologic Malignancies
  • Title

  • Status

  • Phase

  • Study number NCT05609942
  • Clinical Trial Name
  • Title
  • Status
  • Phase
  • Study number
  • Clinical Trial Name ROVER: A Study of Avapritinib in Pediatric Patients with Solid Tumors Dependent on KIT or PDGFRA Signaling
  • Title

  • Status

  • Phase

  • Study number NCT04773782
  • Clinical Trial Name
  • Title
  • Status
  • Phase
  • Study number
  • Clinical Trial Name VELA: A Study of BLU-222 in Advanced Solid Tumors
  • Title

  • Status

  • Phase

  • Study number NCT05252416

Contact Blueprint Medicines

Submit a Medical Inquiry Request information about our products.

Contact a Medical Science LiaisonOur representatives are available to help you with your medical inquiries.

Blueprint Medicines is a pharmaceutical company focusing on the research, development, and commercialization of products in oncology, hematology, and rare diseases. This website is for US healthcare professionals for educational purposes only. Scientific information and data may include investigational use(s) of compounds for which efficacy and safety have not been established. Blueprint Medicines does not promote or endorse the use of its products in a manner not consistent with the approved label.